These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35430212)

  • 1. LncRNAS-modulators of neurovascular units in diabetic retinopathy.
    Pu S; Xu Y; Li X; Yu Z; Zhang Y; Tong X; Shan Y; Gao X
    Eur J Pharmacol; 2022 Jun; 925():174937. PubMed ID: 35430212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus.
    Li X; Zhu J; Zhong Y; Liu C; Yao M; Sun Y; Yao W; Ni X; Zhou F; Yao J; Jiang Q
    EBioMedicine; 2022 Mar; 77():103857. PubMed ID: 35172268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
    Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
    Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.
    Chang X; Zhu G; Cai Z; Wang Y; Lian R; Tang X; Ma C; Fu S
    Front Endocrinol (Lausanne); 2021; 12():771552. PubMed ID: 34858342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic and therapeutic perspectives of non-coding RNA-modulated apoptotic signaling in diabetic retinopathy.
    Wu Q; Liu C; Shu X; Duan L
    Cell Biol Toxicol; 2024 Jul; 40(1):53. PubMed ID: 38970639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovascular regulation in diabetic retinopathy and emerging therapies.
    Ji L; Tian H; Webster KA; Li W
    Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
    Shao J; Zhang Y; Fan G; Xin Y; Yao Y
    BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNAs and Mitochondrial Homeostasis in the Development of Diabetic Retinopathy.
    Kowluru RA
    Front Endocrinol (Lausanne); 2022; 13():915031. PubMed ID: 35733767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA AK077216 is downregulated in diabetic retinopathy and inhibited the apoptosis of retinal pigment epithelial cells by downregulating miR-383.
    Zhang X; Shi E; Yang L; Fu W; Hu F; Zhou X
    Endocr J; 2019 Nov; 66(11):1011-1016. PubMed ID: 31391356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy in the retinal neurovascular unit: New perspectives into diabetic retinopathy.
    Yang X; Huang Z; Xu M; Chen Y; Cao M; Yi G; Fu M
    J Diabetes; 2023 May; 15(5):382-396. PubMed ID: 36864557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA
    Radhakrishnan R; Kowluru RA
    Diabetes; 2021 Jan; 70(1):227-239. PubMed ID: 33051272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway.
    He Y; Dan Y; Gao X; Huang L; Lv H; Chen J
    Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E598-E608. PubMed ID: 33284093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy.
    Thomas AA; Biswas S; Feng B; Chen S; Gonder J; Chakrabarti S
    Diabetologia; 2019 Mar; 62(3):517-530. PubMed ID: 30612136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of noncoding RNAs in diabetic retinopathy: Mechanisms and therapeutic implications.
    Xiao J; Xu Z
    Life Sci; 2024 Nov; 357():123092. PubMed ID: 39368772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ANRIL knockdown ameliorates retinopathy in diabetic rats by inhibiting the NF-κB pathway.
    Wei JC; Shi YL; Wang Q
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7732-7739. PubMed ID: 31599399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA Hotair facilitates retinal endothelial cell dysfunction in diabetic retinopathy.
    Zhao D; Zhao Y; Wang J; Wu L; Liu Y; Zhao S; Guo F; Ma X; Zhang H; Li Z; Meng D; Xu L; Zhang L; Liu J; Qin G
    Clin Sci (Lond); 2020 Sep; 134(17):2419-2434. PubMed ID: 32812634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.
    Moran EP; Wang Z; Chen J; Sapieha P; Smith LE; Ma JX
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H738-49. PubMed ID: 27473938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Long Noncoding RNA MIAT in the Retina of Diabetic Rats with Tail-vein Injection of Human Umbilical-cord Mesenchymal Stem Cells.
    Yu C; Yang K; Meng X; Cao B; Wang F
    Int J Med Sci; 2020; 17(5):591-598. PubMed ID: 32210708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA XIST restrains the activation of Müller cells and inflammation in diabetic retinopathy via stabilizing SIRT1.
    Zhang J; Chen C; Zhang S; Chen J; Wu L; Chen Z
    Autoimmunity; 2021 Dec; 54(8):504-513. PubMed ID: 34498499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.